Life expectancy without a transplant for status 1A liver transplant candidates

Nicholas L Wood1, Douglas N VanDerwerken1, Elizabeth A King2

  • 1Department of Mathematics, United States Naval Academy, Annapolis, Maryland, USA.

Insights

Liver transplant candidates with status 1A have a life expectancy over three times longer than the 7-day policy requirement. This finding suggests a need to align Organ Procurement and Transplantation Network policy with observed survival data for equitable organ allocation.

Area of Science:

  • Transplant medicine
  • Organ allocation policy
  • Biostatistics

Background:

  • Status 1A designation grants the highest priority for deceased donor liver allocation.
  • Organ Procurement and Transplantation Network (OPTN) policy mandates a life expectancy of less than 7 days without a transplant for 1A status.
  • Specific medical conditions are required for 1A status eligibility.

Purpose of the Study:

  • To evaluate the actual life expectancy of status 1A liver transplant candidates.
  • To compare observed life expectancy with the OPTN policy requirement of <7 days.
  • To assess if subgroups of 1A candidates meet the policy's life expectancy criteria.

Main Methods:

  • Utilized data from the Scientific Registry of Transplant Recipients (2010-2020).
  • Employed a bias-corrected Kaplan-Meier model to estimate survival and life expectancy.
  • Analyzed overall status 1A candidates and specific subgroups based on qualifying medical conditions.

Main Results:

  • Status 1A liver transplant candidates have an estimated life expectancy of 24 days without a transplant (95% CI 20-46).
  • This observed life expectancy is more than three times the 7-day threshold set by OPTN policy.
  • No subgroup of 1A candidates, based on their medical conditions, met the <7-day life expectancy requirement.

Conclusions:

  • Current OPTN policy for status 1A liver transplant candidates is not aligned with observed patient data.
  • Observed life expectancy for 1A candidates significantly exceeds the policy's <7-day requirement.
  • Harmonizing OPTN policy with empirical data is crucial for maintaining the integrity of liver allocation.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
92
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
99
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
582
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
624